Table 1.
Up-regulated genes in BMDCs treated with SLC for 1 or 12 hours
| Unigene | Genebank | Description | Gene name | Exp.1 | Exp.2 | Exp.2/Exp.1 |
|---|---|---|---|---|---|---|
|
Ca2+ pathway |
|
|
|
|
|
|
| Mm.3064 |
NM_007922 |
M.musculus mRNA for elk1 protein |
Elk-1 |
1.509E-01 |
3.941E-01 |
2.612E + 00 |
| Mm.195050 |
NM_007923 |
ELK4, member of ETS oncogene family |
Sap 1a |
2.183E-02 |
1.673E-01 |
7.662E + 00 |
|
PKC pathway |
|
|
|
|
|
|
| Mm.896 |
NM_008362 |
Interleukin 1 receptor, type I |
IL-1R1 |
1.194E-04 |
9.819E-04 |
8.223E + 00 |
|
Protein tyrosine kinase pathway |
|
|
|
|
|
|
| Mm.22288 |
NM_007631 |
Cyclin D1 |
Cyclin D1 |
2.426E-02 |
3.758E-01 |
1.549E + 01 |
| Mm.16110 |
NM_007633 |
Cyclin E1 |
Ccnel |
4.159E-02 |
2.403E-01 |
5.778E + 00 |
| Mm.35867 |
NM_009830 |
Cyclin E2 |
Cyclin E2 |
2.048E-01 |
4.335E-01 |
2.117E + 00 |
|
NF-κB pathway |
|
|
|
|
|
|
| Mm.76649 |
NM_011693 |
Vascular cell adhesion molecule 1 |
VCAM-1 |
9.880E-02 |
2.347E-01 |
2.376E + 00 |
|
JAK-STAT pathway |
|
|
|
|
|
|
| Mm.34446 | NM_007669 | Cyclin-dependent kinase inhibitor 1A (P21) | p21Waf1/p21cip | 8.938E-03 | 7.725E-02 | 8.642E + 00 |
Exp.1 represented the expression of the genes in BMDCs treated with SLC for 1 hour; Exp.2 represented the expression of genes in BMDCs treated with SLC for 12 hours; Exp.2/Exp.1 meant the fold change.